MENU
CARM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Carisma Therapeutics (CARM) Ownership - Who owns Carisma Therapeutics?
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma’s proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases... Show more
Profile
Industry
N/A
Address
3675 Market Street
Phone
+1 267 491-6422
Employees
107
Web
https://www.carismatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.87M
P/E Ratio
N/A
Total Cash
7.74M
Projected Growth
N/A
Total Debt
2.33M
Revenue
19.96M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
0.48 USD as % of share price
Fundamentals
CARM
Capitalization
18.9M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
7.74M
Total Cash/Share
0.19
Total Debt
2.33M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.48%
Revenue
20M
ROE
N/A
Book Value
-36.66M
P/B Ratio
114.94
Cash Flow
N/A
Earnings
-1.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
41K
Current Ratio
1.34
Current Revenue Per Employee
81065.22
Dividends Per Share - Security
N/A
EBITDA
-49.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-113.13
Shares Held By Institutions
2.89M
Shares Outstanding - Current
41.8M
Total Liabilities
52.6M
Total Volume MTD
N/A
Value
-1
Gain YTD
7.832
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3675 Market Street
Phone
+1 267 491-6422
Employees
107
Web
https://www.carismatx.com